Literature DB >> 19941413

Telomere length and outcome in heart failure.

Pim van der Harst1, Rudolf A de Boer, Nilesh J Samani, Liza S M Wong, Jardi Huzen, Veryan Codd, Hans L Hillege, Adriaan A Voors, Wiek H van Gilst, Tiny Jaarsma, Dirk J van Veldhuisen.   

Abstract

BACKGROUND: Telomeres are causally involved in senescence. Senescence is a potential factor in the pathogenesis and progression of heart failure. In heart failure telomeres are shorter, but the prognostic value associated with telomere length has not been defined.
METHODS: Telomere length was prospectively determined by quantitative polymerase chain reaction in 890 patients with New York Heart Association (NYHA) functional class II to IV heart failure. After 18 months, we examined the association between telomere length and the predefined primary end-point: time to death or hospitalization for heart failure.
RESULTS: Mean age of the patients was 71 years, 39% were women, 51% were in NYHA class II, and 49% were in class III/IV. A total of 344 patients reached the primary end-point (130 deaths and 214 hospitalizations). Patients with shorter telomeres were at an increased risk of reaching the primary end-point (hazard ratio 1.79; 95% confidence interval (CI) 1.21-2.63). In multivariate analysis shorter telomere length remained associated with a higher risk for death or hospitalization (hazard ratio, 1.74; 95% CI 1.07-2.95) after adjustment for age of heart failure onset, gender, hemoglobin, renal function, and N-terminal pro-B-type natriuretic peptide level, a history of stroke, atrial fibrillation, and diabetes.
CONCLUSIONS: Shorter length of telomeres predicts the occurrence of death or hospitalization in patients with chronic heart failure.

Entities:  

Mesh:

Substances:

Year:  2010        PMID: 19941413     DOI: 10.3109/07853890903321567

Source DB:  PubMed          Journal:  Ann Med        ISSN: 0785-3890            Impact factor:   4.709


  15 in total

Review 1.  Telomeres and mitochondria in the aging heart.

Authors:  Javid Moslehi; Ronald A DePinho; Ergün Sahin
Journal:  Circ Res       Date:  2012-04-27       Impact factor: 17.367

2.  Telomere length and adrenergic-induced left ventricular dilatation and systolic chamber dysfunction in rats.

Authors:  Andrew R Raymond; Bryan Hodson; Angela J Woodiwiss; Gavin R Norton; Richard L Brooksbank
Journal:  Eur J Appl Physiol       Date:  2013-09-06       Impact factor: 3.078

Review 3.  Molecular basis of functional myogenic specification of Bona Fide multipotent adult cardiac stem cells.

Authors:  Eleonora Cianflone; Iolanda Aquila; Mariangela Scalise; Pina Marotta; Michele Torella; Bernardo Nadal-Ginard; Daniele Torella
Journal:  Cell Cycle       Date:  2018-06-25       Impact factor: 4.534

Review 4.  Telomere shortening and Alzheimer's disease.

Authors:  Zhiyou Cai; Liang-Jun Yan; Anna Ratka
Journal:  Neuromolecular Med       Date:  2012-11-16       Impact factor: 3.843

5.  Childhood adversity heightens the impact of later-life caregiving stress on telomere length and inflammation.

Authors:  Janice K Kiecolt-Glaser; Jean-Philippe Gouin; Nan-Ping Weng; William B Malarkey; David Q Beversdorf; Ronald Glaser
Journal:  Psychosom Med       Date:  2010-12-10       Impact factor: 4.312

6.  Cellular aging and restorative processes: subjective sleep quality and duration moderate the association between age and telomere length in a sample of middle-aged and older adults.

Authors:  Matthew R Cribbet; McKenzie Carlisle; Richard M Cawthon; Bert N Uchino; Paula G Williams; Timothy W Smith; Heather E Gunn; Kathleen C Light
Journal:  Sleep       Date:  2014-01-01       Impact factor: 5.849

7.  Leukocyte telomere length in major depression: correlations with chronicity, inflammation and oxidative stress--preliminary findings.

Authors:  Owen M Wolkowitz; Synthia H Mellon; Elissa S Epel; Jue Lin; Firdaus S Dhabhar; Yali Su; Victor I Reus; Rebecca Rosser; Heather M Burke; Eve Kupferman; Mariana Compagnone; J Craig Nelson; Elizabeth H Blackburn
Journal:  PLoS One       Date:  2011-03-23       Impact factor: 3.240

Review 8.  Healthy aging and disease: role for telomere biology?

Authors:  Haidong Zhu; Matthew Belcher; Pim van der Harst
Journal:  Clin Sci (Lond)       Date:  2011-05       Impact factor: 6.124

Review 9.  Aging, telomeres and heart failure.

Authors:  Liza S M Wong; Pim van der Harst; Rudolf A de Boer; Jardi Huzen; Wiek H van Gilst; Dirk J van Veldhuisen
Journal:  Heart Fail Rev       Date:  2010-09       Impact factor: 4.214

10.  Telomere length of circulating leukocyte subpopulations and buccal cells in patients with ischemic heart failure and their offspring.

Authors:  Liza S M Wong; Jardi Huzen; Rudolf A de Boer; Wiek H van Gilst; Dirk J van Veldhuisen; Pim van der Harst
Journal:  PLoS One       Date:  2011-08-18       Impact factor: 3.240

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.